Dopamine Receptor-Deficient Mice 2 Striatum of D Facilitated Glutamatergic Transmission in the
暂无分享,去创建一个
R. Roth | D. Ghahremani | M. Low | M. Levine | R. Hurst | K. Altemus | C. Calvert | M. A. Ariano | M. Mandelkern | E. Seu | Arun Singh | Y. Kaneoke | E. London | A. Morales | K. Grandy | S. Papa | A. James | C. Robertson | M. Kohno | Xuebing Cao | Li Liang | S. Tran | Taylor A. Clark | Christopher R. Calvert | Joanna Burtner | M. Ariano | A. Morgan | Karen Feiler | M. Crawford | J. David | M. Groman
[1] D. Grandy,et al. The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice , 2000, Neuroscience.
[2] G Bernardi,et al. Synaptic transmission in the striatum: from plasticity to neurodegeneration , 2000, Progress in Neurobiology.
[3] R. Depoortère,et al. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. , 2000, European journal of pharmacology.
[4] T. Momiyama,et al. Presynaptic dopamine D2‐like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones , 2000, The Journal of physiology.
[5] M. Low,et al. The Dopamine D2, but not D3 or D4, Receptor Subtype is Essential for the Disruption of Prepulse Inhibition Produced by Amphetamine in Mice , 1999, The Journal of Neuroscience.
[6] J. Delfs,et al. Presynaptic Inhibition of GABAB-Mediated Synaptic Potentials in the Ventral Tegmental Area during Morphine Withdrawal , 1999, The Journal of Neuroscience.
[7] C. Cepeda,et al. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons , 1998, The European journal of neuroscience.
[8] S. Haber,et al. Dopamine Neurons Make Glutamatergic Synapses In Vitro , 1998, The Journal of Neuroscience.
[9] M. Low,et al. Locomotor Activity in D2 Dopamine Receptor-Deficient Mice Is Determined by Gene Dosage, Genetic Background, and Developmental Adaptations , 1998, The Journal of Neuroscience.
[10] J. Bargas,et al. Ca2+-Channels Involved in Neostriatal Glutamatergic Transmission , 1998, Brain Research Bulletin.
[11] C. Cepeda,et al. Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum , 1998, Developmental Neuroscience.
[12] P. Calabresi,et al. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum , 1997, Neuroscience & Biobehavioral Reviews.
[13] J. A. Chester,et al. Mice Lacking Dopamine D4 Receptors Are Supersensitive to Ethanol, Cocaine, and Methamphetamine , 1997, Cell.
[14] F. Holsboer. Transgenic Mouse Models: New Tools for Psychiatric Research , 1997 .
[15] P. Calabresi,et al. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. , 1997, Neuroscience.
[16] Allan Collins,et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies , 1997, Psychopharmacology.
[17] P. Calabresi,et al. Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors , 1997, The Journal of Neuroscience.
[18] J. Bargas,et al. Dopamine selects glutamatergic inputs to neostriatal neurons , 1997, Synapse.
[19] I. Forsythe,et al. Presynaptic Calcium Current Modulation by a Metabotropic Glutamate Receptor , 1996, Science.
[20] H. C. Cromwell,et al. Modulatory Actions of Dopamine on NMDA Receptor-Mediated Responses Are Reduced in D1A-Deficient Mutant Mice , 1996, The Journal of Neuroscience.
[21] Charles J. Wilson,et al. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[22] P. Calabresi,et al. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia , 1996, Trends in Neurosciences.
[23] A. Saiardi,et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.
[24] J. Bolam,et al. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] J. Bargas,et al. Patterns of excitatory and inhibitory synaptic transmission in the rat neostriatum as revealed by 4-AP. , 1994, Journal of neurophysiology.
[26] D. Lovinger,et al. Involvement of N- and non-N-type calcium channels in synaptic transmission at corticostriatal synapses , 1994, Neuroscience.
[27] D. Sibley,et al. D2 dopamine receptor protein location: Golgi impregnation‐gold toned and ultrastructural analysis of the rat neostriatum , 1994, Journal of neuroscience research.
[28] J. Walsh,et al. Neurophysiological, pharmacological and morphological properties of human caudate neurons recorded in vitro , 1994, Neuroscience.
[29] S. Sesack,et al. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[30] C. Cepeda,et al. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] G Bernardi,et al. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. , 1993, Brain : a journal of neurology.
[32] B. Yamamoto,et al. Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis , 1992, Journal of neurochemistry.
[33] D. Grandy,et al. Molecular biology of the dopamine receptors. , 1991, European journal of pharmacology.
[34] S. Young,et al. Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation , 1991, Brain Research.
[35] W. Armstrong,et al. A biotin-containing compound N-(2-aminoethyl)biotinamide for intracellular labeling and neuronal tracing studies: Comparison with biocytin , 1991, Journal of Neuroscience Methods.
[36] D. Sibley,et al. Characterization of anti-peptide antibodies for the localization of D2 dopamine receptors in rat striatum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] G Maura,et al. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release. , 1989, The Journal of pharmacology and experimental therapeutics.
[38] G Maura,et al. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. , 1988, The Journal of pharmacology and experimental therapeutics.
[39] P. Calabresi,et al. Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: Intracellular studies from naive and catecholamine-depleted rats , 1988, Neuroscience.
[40] J. Bargas,et al. Spontaneous synaptic potentials in dopamine-denervated neostriatal neurons , 1987, Neuroscience Letters.
[41] D. Johnston,et al. 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. , 1987, Journal of neurophysiology.
[42] P. Calabresi,et al. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: Evidence for D1 receptor involvement , 1987, Neuroscience.
[43] P. Calabresi,et al. Intrinsic membrane properties of neostriatal neurons can account for their low level of spontaneous activity , 1987, Neuroscience.
[44] G. Wooten,et al. Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography , 1986, Nature.
[45] J. Kornhuber,et al. Presynaptic dopaminergic modulation of cortical input to the striatum. , 1986, Life sciences.
[46] G. Levi,et al. Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms , 1985, Brain Research.
[47] A. Zharikova,et al. Role of presynaptic dopamine receptors in regulation of the glutamatergic neurotransmission in rat neostriatum , 1984, Neuroscience.
[48] J. Brown,et al. The electrophysiology of dopamine (D2) receptors: A study of the actions of dopamine on corticostriatal transmission , 1983, Neuroscience.
[49] Wolfram Schultz,et al. Depletion of dopamine in the striatum as an experimental model of parkinsonism: direct effects and adaptive mechanisms , 1982, Progress in Neurobiology.
[50] S. Thesleff,et al. Aminopyridines and synaptic transmission , 1980, Neuroscience.
[51] P. Spano,et al. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. , 1978, Life sciences.
[52] S. Snyder,et al. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.
[53] S. W. Kuffler,et al. Presynaptic inhibition at the crayfish neuromuscular junction , 1961, The Journal of physiology.
[54] Carlos Cepeda,et al. Dopamine — Glutamate Interactions , 2002 .
[55] C. Cepeda,et al. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. , 1998, Journal of neurophysiology.
[56] A. Saiardi,et al. The physiological role of dopamine D2 receptors. , 1998, Advances in pharmacology.
[57] C. Cepeda,et al. Dopamine modulation of responses mediated by excitatory amino acids in the neostriatum. , 1998, Advances in pharmacology.
[58] D. Sibley,et al. Molecular biology of dopamine receptors. , 1992, Trends in pharmacological sciences.
[59] J. Walsh,et al. Dye‐Coupling in the neostriatum of the rat: I. Modulation by dopamine‐depleting lesions , 1989, Synapse.
[60] J. Venter,et al. Receptor Biochemistry ahd Methodology , 1984 .